Medline Inc. Class A Common Stock Cash Flow Conversion Efficiency

Latest as of June 2026: 0.037x

Medline Inc. Class A Common Stock cash flow conversion efficiency. Based on the latest financial reports, Medline Inc. Class A Common Stock (MDLN) has a cash flow conversion efficiency ratio of 0.037x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($715.00 Million) by net assets ($19.08 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Medline Inc. Class A Common Stock (2023–2025)

Cash flow conversion efficiency of Medline Inc. Class A Common Stock from 2023 to 2025. This chart illustrates how Medline Inc. Class A Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. View MDLN live share price for real-time trading data and today's change.

Medline Inc. Class A Common Stock Cash Flow Conversion Ratio Explained

Medline Inc. Class A Common Stock cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Medline Inc. Class A Common Stock Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medline Inc. Class A Common Stock ranked by their cash flow conversion efficiency. Also see MDLN market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Copart Inc
NASDAQ:CPRT
0.013x
Everpure, Inc.
NYSE:P
0.125x
Cheniere Energy Partners LP
NYSE:CQP
11.667x
Otis Worldwide Corp
NYSE:OTIS
-0.071x
Iron Mountain Incorporated
NYSE:IRM
-0.440x
Shinhan Financial Group Co Ltd
NYSE:SHG
0.219x
Roblox Corp
NYSE:RBLX
1.400x
Bajaj Finserv Limited
NSE:BAJAJFINSV
-0.180x

Annual Cash Flow Conversion Efficiency for Medline Inc. Class A Common Stock (2023–2025)

The table below shows the annual cash flow conversion efficiency of Medline Inc. Class A Common Stock from 2023 to 2025. Review MDLN free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $19.29 Billion $1.74 Billion 0.090x -15.53%
2024-12-31 $16.52 Billion $1.77 Billion 0.107x +7.86%
2023-12-31 $16.98 Billion $1.69 Billion 0.099x --

About Medline Inc. Class A Common Stock

NASDAQ:MDLN USA Medical Instruments & Supplies
Market Cap
$29.91 Billion
Market Cap Rank
#886 Global
#395 in USA
Share Price
$34.09
Change (1 day)
+1.37%
52-Week Range
$31.64 - $62.00
All Time High
$62.00
About

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front … Read more